Your AI-Trained Oncology Knowledge Connection!

Jane Meza, PhD

Articles by Jane Meza, PhD

A Phase 2 Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and Neck

ByOmar K. Abughanimeh, MBBS,Nicole A. Shonka, MD,Jane Meza, PhD,Lynette Smith, PhD,Irfan A. Vaziri, MD,Mehmet Sitki Copur, MD,Robin High, MBA,Kimberly Shields, BSN, RN,Holly DeSpiegelaere, BSN, RN,Anne Kessinger, MD,Apar Kishor Ganti, MD, MS

August 13th 2025

This study explores the efficacy and safety of combining docetaxel and capecitabine for treating recurrent or metastatic head and neck cancer.

Latest Updated Articles

A Phase 2 Study of Docetaxel and Capecitabine in Advanced Squamous Cell Carcinoma of the Head and Neck
Published: August 13th 2025 | Updated:

Trending on CancerNetwork

FDA Advises Against BLA for Novel Vaccine Combo/Pembrolizumab in Melanoma

Moving Beyond Chemotherapy in Relapsed/Refractory ES-SCLC Treatment

TTFields After SRS Prolongs Intracranial Response in Brain Metastatic NSCLC

Treatment Decision-Making in Multiple Myeloma at First and Subsequent Relapses

Anito-cel Yields Enduring Efficacy in Relapsed/Refractory Multiple Myeloma

© 2025 MJH Life Sciences^®

All rights reserved.